Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alimera Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alimera Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alimera Sciences Enters into Distribution Agreement with Horus Pharma 11
Alimera Sciences Enters into Distribution Agreement with Brill Pharma 12
Alimera Sciences Enters into Distribution Agreement with MEAgate 13
Alimera Sciences Enters into Distribution Agreement with SIFI for Iluvien 14
Alimera Sciences Enters into Distribution Agreement with Knight Therapeutics 15
Alimera Sciences Enters Into Distribution Agreement With Specialised Therapeutics For Iluvien 16
Equity Offering 17
Alimera Sciences Plans to Raise up to USD100 Million in Public Offering of Securities 17
Alimera Sciences Raises USD1.2 Million in Public Offering of Shares 18
Alimera Sciences Raises USD26.5 Million in Public Offering of Shares 19
Alimera Sciences Raises USD0.8 Million in Private Placement of Shares 21
Alimera Sciences Raises USD50 Million in Private Placement of Preferred Stock 22
Alimera Sciences Raises USD35 Million in Public Offering of Shares 24
Alimera Sciences Completes Private Placement Of Shares For US$37.5 Million 25
Alimera Sciences Completes Private Placement Of Units For US$40 Million 26
Acquisition 28
Alimera Sciences Mulls for Sale 28
Alimera Sciences Inc – Key Competitors 29
Alimera Sciences Inc – Key Employees 30
Alimera Sciences Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Nov 05, 2018: Alimera Sciences reports third quarter 2018 results 32
Jul 31, 2018: Alimera Sciences Reports Second Quarter 2018 Results 34
May 02, 2018: Alimera Sciences Reports First Quarter 2018 Results 36
Feb 28, 2018: Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results 38
Nov 01, 2017: Alimera Sciences Reports Third Quarter 2017 Financial Results 40
Aug 02, 2017: Alimera Sciences Reports Second Quarter 2017 Financial Results 42
May 08, 2017: Alimera Sciences Reports First Quarter 2017 Financial Results 44
Mar 01, 2017: Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results 46
Corporate Communications 48
Jun 21, 2018: Alimera Sciences Names Mary T. Szela As Board Director 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alimera Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alimera Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Alimera Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alimera Sciences Enters into Distribution Agreement with Horus Pharma 11
Alimera Sciences Enters into Distribution Agreement with Brill Pharma 12
Alimera Sciences Enters into Distribution Agreement with MEAgate 13
Alimera Sciences Enters into Distribution Agreement with SIFI for Iluvien 14
Alimera Sciences Enters into Distribution Agreement with Knight Therapeutics 15
Alimera Sciences Enters Into Distribution Agreement With Specialised Therapeutics For Iluvien 16
Alimera Sciences Plans to Raise up to USD100 Million in Public Offering of Securities 17
Alimera Sciences Raises USD1.2 Million in Public Offering of Shares 18
Alimera Sciences Raises USD26.5 Million in Public Offering of Shares 19
Alimera Sciences Raises USD0.8 Million in Private Placement of Shares 21
Alimera Sciences Raises USD50 Million in Private Placement of Preferred Stock 22
Alimera Sciences Raises USD35 Million in Public Offering of Shares 24
Alimera Sciences Completes Private Placement Of Shares For US$37.5 Million 25
Alimera Sciences Completes Private Placement Of Units For US$40 Million 26
Alimera Sciences Mulls for Sale 28
Alimera Sciences Inc, Key Competitors 29
Alimera Sciences Inc, Key Employees 30
Alimera Sciences Inc, Subsidiaries 31
List of Figures
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alimera Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9